Related Experiment Video
Updated: Mar 2, 2026
Three-Dimensional Echocardiographic Method for the Visualization and Assessment of Specific Parameters of the Pulmonary Veins
Published on: October 28, 2020
[Pulmonary vein isolation for atrial fibrillation : Findings from long-term follow-up]
C-H Heeger1, K-H Kuck2, F Ouyang2
1Abteilung für Kardiologie - Klinische Elektrophysiologie, Asklepios Klinik St. Georg, Lohmühlenstraße 5, 20099, Hamburg, Deutschland. Christian.heeger@gmx.net.
Insights
Atrial fibrillation (AF), a common heart rhythm disorder, impacts many due to aging populations. This review covers long-term outcomes of pulmonary vein isolation (PVI), a key treatment for AF.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Atrial fibrillation (AF) is the most prevalent human cardiac arrhythmia.
- AF incidence rises with age, posing increasing clinical and socioeconomic challenges.
- AF is a significant risk factor for stroke, heart failure, and cardiovascular mortality.
Purpose of the Study:
- To summarize current long-term follow-up data following pulmonary vein isolation (PVI).
Main Methods:
- Review of existing literature on long-term outcomes after PVI for atrial fibrillation.
Main Results:
- Pulmonary vein isolation (PVI) is recommended by current guidelines for treating paroxysmal and persistent atrial fibrillation.
- The article focuses on summarizing the available long-term follow-up data regarding the efficacy and safety of PVI.
Conclusions:
- Pulmonary vein isolation (PVI) is an established invasive treatment for atrial fibrillation (AF).
- Understanding long-term follow-up data is crucial for assessing the sustained effectiveness of PVI in managing AF.
Abstract:
Atrial fibrillation is by far the most common cardiac arrhythmia in humans. The incidence of atrial fibrillation increases with age and will increase even more in the future due to the demographic changes in the population. Therefore, this arrhythmia will have a growing clinical and socioeconomic impact. Although there are established pharmaceutical treatment options, atrial fibrillation is one of the major causes of stroke, heart failure and cardiovascular morbidity and mortality. The latest guidelines recommend the invasive procedure of circumferential pulmonary vein isolation (PVI) as an effective treatment of paroxysmal and persistent atrial fibrillation. This article summarizes the current long-term follow-up data after PVI.
